GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » M3 Inc (TSE:2413) » Definitions » Loans Receivable
中文

M3 (TSE:2413) Loans Receivable : 円0 Mil (As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is M3 Loans Receivable?

M3's Loans Receivable for the quarter that ended in Dec. 2023 was 円0 Mil.


M3 Loans Receivable Historical Data

The historical data trend for M3's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

M3 Loans Receivable Chart

M3 Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

M3 Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

M3 Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


M3 Loans Receivable Related Terms

Thank you for viewing the detailed overview of M3's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


M3 (TSE:2413) Business Description

Traded in Other Exchanges
Address
Akasaka Intercity 10th floor, 1-11-44 Akasaka, Minato-ku, Tokyo, JPN, 105-0012
M3, Inc. is a Japan-based company engaged in providing medical-related services through the use of the Internet. It also supports marketing of pharmaceutical companies and medical equipment manufacturers. The company's business segment includes, Medical Portal segment, Evidence Solution segment, Overseas segment, Clinical Platform segment, Sales Platform segment, and Others. The company generates the majority of its revenue from Medical Portal segment.

M3 (TSE:2413) Headlines

No Headlines